Distyl AI vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Distyl AI

ChallengerArtificial Intelligence

Enterprise AI Implementation

Raised $175M Series B (Sep 2025) at $1.8B valuation led by Lightspeed and Khosla. Revenue 5x in 2024, tracking 8x in 2025. 120M+ end users. Founded by ex-Palantir engineers.

About

Distyl AI is an enterprise AI implementation company that makes Fortune 500 organizations "AI-native" — deploying tailored AI solutions across operational workflows in telecommunications, insurance, manufacturing, and financial services. The company raised $175 million in Series B financing in September 2025 at a $1.8 billion valuation, led by Lightspeed Venture Partners and Khosla Ventures. Revenue grew 5x in 2024 and was tracking 8x growth in 2025, with 120 million+ end users reached through enterprise deployments.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.